In chronic hepatic disease, the accumulation of fluid as ascites or edema is commonly observed (1) . A similar tendency can also be demonstrated in acute hepatic disease, often in the absence of clinically detectable ascites or edema (2) (3) (4) , suggesting that a common fluid-retaining factor may operate in both chronic and acute diseases.
Although diminished plasma colloidal osmotic pressure, resulting from lowered plasma albumen levels, has been put forward by some observers as the chief fluid-retaining factor in chronic liver disease (5-7) others have failed to find a constant correlation between the appearance of ascites and edema on the one hand and plasma albumen levels on the other (8, 9) . Furthermore, the fluid retention of acute hepatic disease is not usually associated with abnormally low plasma albumen concentrations (2) .
In search for other fluid-retaining factors, the possibility was suggested that in liver disease the hepatic inactivation of fluid-retaining hormones might be impaired, and from this point of view Ralli, Robson, Clarke, and Hoagland (10) , investigated the role of the pituitary anti-diuretic hormone.
However, it seemed more probable that a primarily sodium-retaining hormone might be involved. Estrogens have been shown to have a salt-retaining action in animals (11) , and there is much evidence to show that in animals these hormones are normally inactivated by the liver (12) . Moreover, in human liver disease there are certain clinical features which are best explained on the basis of increased estrogen activity (13) (14) (15) . These observations suggest that decreased inactivation of endogenous estrogen may occur in human liver disease, which may lead in turn to sodium-retention. Under these circumstances the administration of exogenous estrogen to cases of liver disease would be expected to result in far greater retention of sodium than in normal subjects (16) .
The effect of the daily administration of estrogen on water and electrolyte metabolism has been studied in cases of human hepatic disease. To elucidate further the mechanism of the changes observed, the study was extended to Tables I  to IV) were omitted. (Table I) Weight. The group mean difference between control and estrogen periods was calculated only from the four cases (Nos. 33, 56, 58, and 62) in which there was no obvious trend during the control period. In the remaining cases, regression lines were calculated for both periods. In all these subjects (except No. 17) a highly significant difference between control and estrogen regres-
RESULTS

Cirrhosis with ascites
-sion lines was observed, the difference indicating an increased rate of weight gain during the estrogen period in case 1, and a slightly decreased rate of gain in case 64. In cases 24, and 28 there was a complete reversal of a downward trend following estrogen administration. In cases 33, 56, 58, and 62, the significance of differences between means could be tested. There was a significant increase of weight in cases 33, 56, and 58.
Water balance. There was a group mean difference between periods of + 283 ml. which was significant. In individual cases an increased mean figure was observed in all cases, except in No. 17, but the difference was of a magnitude to attain significance only in cases 24, 28, and 33.
Daily urinary outputs. Cl and Na. There was a group mean difference between periods of -36 mEq. Cl and -46 mEq. Na, each difference being highly significant. A significantly decreased mean output of Cl and Na during the estrogen period was observed in each subject, except in Nos. 56, 58, and 62. In No. 58 the decrease in both Cl and Na was of borderline significance, and in case 62 the decrease in Na was significant, but that in Cl was not. In case 56 no significant variation in either Cl or Na occurred during the estrogen period.
K. This estimation was performed in seven cases. There was no significant difference between periods as a group. In case 56, there was a small but significant increase in average output of K, and in case 64 a small but significant decrease. P04. Phosphate output was studied in four cases. The group mean difference was not significant and there was no significant difference between period means in any individual case.
Total serum protein.
There was a mean decrease of 0.57 g. per 100 ml., which was of borderline significance. This represents a mean decrease of 8 per cent of control values.
Venous hematocrit. A mean decrease of 1.7 per cent was observed in the seven cases in which this observation was made. Water tolerance test. Mean results for the five cases studied are given in Table IV . The hourly differences were either non-significant or of borderline significance, but the mean difference for all hours and all cases (-67 ml.) was highly significant (P = 0.01).
In contrast to the normal findings there was a marked and sustained fall in daily average urinary Na output (Figure 1 Plasma Cl and Na levels. No significant change was observed in the level of either ion (group mean differences, + 0.2 mEq. per L. Cl and + 0.6 mEq. per L. Na, P = 0.8 in each case).
Water tolerance test (Table IV) . This test was performed in five cases. The group mean difference between periods for all hours and all cases of -39 ml. was not significant. Analysis of results by hours shows that there was a significant difference following estrogen administration only in the second hour (d = -100 ml., P = 0.01). Figure 3 indicates that there was no marked difference between the cirrhotic group and the normal in respect of average daily weight or water balance, but average daily Na outputs in the cirrhotic group were somewhat lower during the estrogen period. In addition, the Na output failed to return to the control mean in nine days, whereas in the normal group, values rose above the control mean in seven days. Daily average urinary Na/Cl ratios did not differ significantly from the normal.
There was an average apparent retention of 126 mEq. Na, 99 mEq. Cl, and 266 ml. water and an average weight gain of 0.74 kg. during the estrogen period. Na and Cl were retained in approximately the proportion expected, if retention were solely due to increased extracellular fluid volume, but the apparent retention of water and the increase in weight were not in the expected proportions.
Obstructive jaundice (Table III) Weight. There was, as a group, no significant change during the estrogen period. Individual records show either no significant change (Nos. 23, 40, 42), or a small but significant decrease of weight during the estrogen period (Nos. 3 and 29) . However, inspection of the individual records in these two cases indicated that a decreasing tendency was already evident during the last days of the control period, although there was no systematic tendency throughout the period as a whole.
Water balance. No significant variation occurred as a group during the estrogen period nor was there any significant variation in any individual case.
Daily urinary outputs. Cl and Na. There was a significant decrease in Cl and Na (group mean differences, -18.8 mEq. Cl, and -20.8 mEq. Na, P = 0.02 in each case).
In individual cases, there was a significant decrease in Cl output alone in cases 3 and 42, and a decrease in Na output alone of borderline significance in cases 23 and 40 (P = 0.03).
K. This estimation was done in four cases. A group mean difference of -9.2 mEq. was of borderline significance (P = 0.04). A decrease of borderline significance also occurred in two individual subjects (Nos. 29 and 40).
P04. There was no significant variation as a group nor was there any significant difference in any of the four individual cases. Venous hematocrit. There was a highly significant mean decrease in packed cell volume of 3 per cent (P = 0.01). This represents a decrease compared with control values of 7.5 per cent.
There was no significant change in either total serum protein levels or in thiocyanate space (mean difference for thiocyanate space + 1.9 L., P = 0.1).
Plasma Cl and Na. There was no significant change following estrogen administration (group mean difference + 0.2 mEq. per L. Cl and + 0.4 mEq. per L. Na, P = 0.9 in each case).
Water tolerance test (Table IV) . The mean difference between control and estrogen periods for all cases and all hours was not significant. Analysis of hourly results indicated no significant difference between periods for any hour. Figure 4 shows that Na output decreased well below the normal range, but rose above control levels by the end of the estrogen period. Water balance rose above the 95 per cent confidence limits, then returned to control values, the variation corresponding to that of Na output. Weight which had been falling steadily during the control period, rose during the estrogen period. Average daily urinary Na/Cl ratios did not however vary significantly between periods. There was an average apparent retention of 178 mEq. Cl and 167 mEq. Na, and 1360 ml. H20 during the estrogen period. There was an average increase in weight (estimated from the last day of the control period) of 0.25 kg. These figures are not in the proportion expected if retention were due solely to an increase in ECF volume.
Infective hepatitis (Table III) .
Weight. (Group analysis was not attempted.) There was a significant increase in weight during the estrogen period in cases 2, 10, and 48, being particularly marked in No. 2. In No. 48, the falling tendency during the control period was reversed following estrogen administration.
Water balance. There was a group mean difference of + 418 ml. between periods, which was of borderline significance (P = 0.04). In cases 10 and 48, there was a significant increase in water balance during the estrogen period. In case 75 the increase was of borderline significance (P -0.05), and in case 2 non-significant.
Daily urinary outputs. Cl and Na. There was no significant group mean variation between periods in the output of either ion. In case 48, there was a significant fall in urinary Cl and Na output during the estrogen period. In the remaining cases there was no significant change.
No significant change was observed in urinary K output, nor in total serum protein, venous hematocrit and plasma Cl and Na levels. Water tolerance tests were carried out in three cases; there was no significant difference between periods.
In the four cases of infective hepatitis estrogen administration had no significant effect as a group on water balance or on urinary Cl and Na output. However, a significant decrease in urinary Na and Cl output, accompanied by a significant increase in weight and water balance, did occur in case 48. Here an NaCl and water diuresis was temporarily reversed on estrogen administration. The individual record showed that a second diuresis occurred when estrogen was discontinued.
Ascites without hepatic disease (Table III) Group analysis was not carried out in these three cases. In case 25, there was a steady increase in weight during the control period due to the accumulation of ascites. Estrogen administration was accompanied by a slight but significant increase in the rate of weight gain. There was a progressive decrease in urinary Na and Cl output during the control period, comparison of regression lines indicating that the rate of decrease became significantly less during the estrogen period. A
significant mean decrease in urinary P04 output was observed during the estrogen period, and there was a reduction in venous hematocrit of 2 per cent. In case 35, there was a steady decrease in weight during the control period, which was significantly reversed during the estrogen period (P = 0.01). No significant change was observed in urinary output of Cl, Na, K, or P04, but total serum protein decreased by 0.9 g. per 100 ml., and the venous hematocrit by 4 per cent. Case 66 was undergoing a slow spontaneous diuresis during the control period. The significant decrease in weight during the estrogen period was attributable to this factor, which also accounted for the significant diminution in water balance, and urinary Na and Cl output. A slight decrease in K output was of borderline significance.
Plasma Cl and Na levels were not significantly affected by estrogen administration in any of these cases. Water tolerance tests performed in cases 25 and 35 showed a mean difference between periods for both cases and all hours of -131 ml., which was of borderline significance (P = 0.03).
There was no indication in any of the three cases that estrogen caused any significant alteration in NaCl and water metabolism.
Portal hypertension without hepatic disease (Table III) Group analyses were not carried out. In both cases studied there was There was no indication that estrogen caused any significant retention of water or NaCl in either case.
DISCUSSION
The considerable and sustained retention of Cl, Na, and water observed in the group of cirrhosis with ascites following the administration of estrogen is in marked contrast with the effect of the same dosage in the normal (16) . The changes in the cirrhotic group were apparent not only in the group as a whole (Table I, Figure 1 and 2) but also in each individual case, save one (No. 56) in which ascites had already disappeared following six weeks' hospital treatment.
In the group of cirrhosis without ascites, on the other hand, the effect of estrogen on NaCl and water metabolism did not differ markedly from the normal. However, although no significant change occurred in any individual case, save one (No. 18), a small but significant retention of Cl and Na was detected on group analysis (Table II, Figure 4 ), indicating that the difference between the two cirrhotic groups of the effect of estrogen administration is quantitative rather than qualitative.
The effect of estrogen on the group of infective hepatitis did not differ from the normal in three cases, but in the fourth (No. 48) estrogen administration was associated with a marked reversal of an existing NaCl and water diuresis similar to that observed in two cases (Nos. 24 and 28) in the group of cirrhosis with ascites. It is of interest that this (No. 48) was the only case of infective hepatitis in which recovery was not already evident by the time estrogen was administered, suggesting that NaCl and water retention might have been observed more often if more severe cases had been available.
The prominent increases in weight in the absence of NaCl retention, observed in some cases of infective hepatitis and cirrhosis without ascites after estrogen, may be attributable to increased tissue formation, as in the normal group (16) .
The evidence (12) that, in sub-primates, the liver is the main site of estrogen inactivation is convincing. Although somewhat more controversial (17) , the balance of evidence indicates that in humans also estrogens are chiefly inactivated in the liver (18, 19) .
The marked NaCl and water storage observed in the present series of cirrhotics with ascites after estrogen administration might be accounted for by failure of a diseased liver to inactivate the hormone. However, the quantitative difference in NaCI and water retention observed between the two cirrhotic groups would then imply differing rates of hepatic estrogen inactivation. Before
